Dr. Li is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Baylor College of Medicine
1 Baylor Plz
Houston, TX 77030Phone+1 713-798-3750Fax+1 713-798-2045
Education & Training
- University of WashingtonFellowship, Hematology and Medical Oncology, 2018
- Massachusetts General HospitalResidency, Internal Medicine, 2012 - 2015
- Baylor College of MedicineClass of 2012
Certifications & Licensure
- TX State Medical License 2019 - 2025
- WA State Medical License 2015 - 2019
- MA State Medical License 2012 - 2015
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 490 citationsFive-Year Follow-Up of Nivolumab in Previously Treated Advanced Non–Small-Cell Lung Cancer: Results From the CA209-003 StudyScott N. Gettinger, Leora Horn, David M. Jackman, David R. Spigel, Scott J. Antonia
Journal of Clinical Oncology. 2018-03-23 - 81 citationsA Self-Deleting AAV-CRISPR System for In Vivo Genome Editing.Ang Li, Ciaran M. Lee, Ayrea Hurley, Kelsey E Jarrett, Marco De Giorgi
Molecular Therapy. Methods & Clinical Development. 2019-03-15 - 126 citationsAAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9Ang Li, Mark R. Tanner, Ciaran M. Lee, Ayrea Hurley, Marco De Giorgi
Molecular Therapy. 2020-06-03
Abstracts/Posters
- Comparative Effectiveness of Rasburicase Versus Allopurinol for Cancer Patients with Renal Dysfunction and HyperuricemiaAng Li, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Patterns and Predictors of Emicizumab Adherence in People with Hemophilia61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- D-Dimer As a Prognostic Biomarker for Venous Thromboembolism after Hematopoietic Cell Transplantation61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Press Mentions
- Does Blood Type Affect Your Risk of Severe COVID-19?July 22nd, 2020
- Does Blood Type Influence Covid-19 Susceptibility?July 13th, 2020
- Blood Type May Affect COVID-19 Outcomes, Study ShowsJune 29th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: